Salvatore De Rosa Selected Research

cacospongionolide B

4/2003

Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore De Rosa Research Topics

Disease

18	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2007
14	Thrombosis (Thrombus) 06/2021 - 10/2004
11	Myocardial Infarction 06/2021 - 08/2007
10	Inflammation (Inflammations) 04/2022 - 10/2004
9	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 06/2007
9	Heart Failure 10/2020 - 03/2011
8	Hemorrhage 01/2022 - 10/2004
8	Acute Coronary Syndrome 03/2020 - 01/2003
7	Stroke (Strokes) 04/2022 - 01/2015
6	Neoplasms (Cancer) 01/2021 - 01/2012
5	Ischemic Stroke 04/2022 - 01/2015
4	COVID-19 01/2021 - 01/2020
4	Vascular System Injuries 01/2018 - 10/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 09/2017
3	Atherosclerosis 01/2021 - 01/2011
3	Atrial Fibrillation 01/2020 - 01/2015
3	Pathologic Constriction (Stenosis) 01/2019 - 01/2015
3	Coronary Stenosis (Coronary Artery Stenosis) 12/2016 - 08/2013
2	Cardiomyopathies (Cardiomyopathy) 10/2022 - 01/2020
2	ST Elevation Myocardial Infarction 06/2021 - 01/2016
2	Infections 01/2021 - 03/2015
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
2	Rupture 06/2020 - 03/2015
2	Diabetes Mellitus 07/2019 - 01/2018
2	Vascular Remodeling 01/2019 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 08/2016 - 04/2015
2	Infarction (Infarctions) 01/2016 - 01/2016
2	Peripheral Arterial Disease 03/2011 - 06/2007
2	Obesity 05/2010 - 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2022
1	Cardiomegaly (Heart Hypertrophy) 10/2022
1	Hypotension (Low Blood Pressure) 12/2021
1	Injection Site Reaction 01/2021
1	Death (Near-Death Experience) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Hypertrophy 01/2021
1	Diabetic Cardiomyopathies 01/2021
1	Weight Loss (Weight Reduction) 01/2020
1	Foreign Bodies (Foreign Body) 12/2019
1	Rhabdomyolysis 07/2019

Drug/Important Bio-Agent (IBA)

20	MicroRNAs (MicroRNA)IBA 04/2022 - 09/2010
13	Biomarkers (Surrogate Marker)IBA 06/2021 - 11/2011
6	omega-Chloroacetophenone (Mace)IBA 01/2021 - 08/2007
4	AnticoagulantsIBA 06/2021 - 01/2015
4	EnzymesIBA 07/2019 - 04/2003
4	Biological ProductsIBA 01/2019 - 01/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2022 - 02/2014
3	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2015
3	SesquiterpenesIBA 08/2016 - 01/2014
3	avarolIBA 08/2016 - 01/2008
3	Thromboplastin (Tissue Factor)IBA 05/2010 - 01/2003
2	evolocumabIBA 01/2021 - 07/2019
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2008
2	alirocumabIBA 01/2021 - 07/2019
2	Pharmaceutical PreparationsIBA 12/2016 - 01/2014
2	hydroquinone (Esoterica)FDA Link 08/2016 - 04/2015
2	AcidsIBA 08/2016 - 04/2015
2	TicagrelorIBA 08/2014 - 02/2014
2	Clopidogrel (Plavix)FDA Link 08/2014 - 02/2014
2	NeopterinIBA 03/2011 - 06/2007
2	LeptinIBA 05/2010 - 01/2009
2	AdipokinesIBA 05/2010 - 01/2009
1	Cardiac GlycosidesIBA 10/2022
1	marinobufageninIBA 10/2022
1	Arachidonic Acid (Vitamin F)IBA 04/2022
1	Insulin (Novolin)FDA Link 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021
1	CalciumIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	MetalsIBA 11/2020
1	pro-brain natriuretic peptide (1-76)IBA 09/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020
1	Peptides (Polypeptides)IBA 09/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2020
1	Dalteparin (Dalteparin Sodium)FDA Link 09/2020
1	vinyltriethoxysilane (VTES)IBA 09/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	empagliflozinIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Proprotein Convertase 9IBA 07/2019

Therapy/Procedure

9	Stents 01/2022 - 01/2013
8	Therapeutics 04/2022 - 02/2013
5	Percutaneous Coronary Intervention 01/2022 - 08/2007
5	Drug-Eluting Stents 11/2020 - 01/2013
3	Transcatheter Aortic Valve Replacement 01/2021 - 09/2017
2	Catheter Ablation 01/2017 - 01/2015
1	Renal Dialysis (Hemodialysis) 12/2021
1	Braces 01/2021
1	Patient Readmission 10/2020
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 06/2020
1	ACT protocol 01/2020
1	Patient Admission (Patient Admissions) 01/2020